[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU1763901A - Mutual suppression between sex hormone receptors and other nuclear receptors - Google Patents

Mutual suppression between sex hormone receptors and other nuclear receptors

Info

Publication number
AU1763901A
AU1763901A AU17639/01A AU1763901A AU1763901A AU 1763901 A AU1763901 A AU 1763901A AU 17639/01 A AU17639/01 A AU 17639/01A AU 1763901 A AU1763901 A AU 1763901A AU 1763901 A AU1763901 A AU 1763901A
Authority
AU
Australia
Prior art keywords
receptors
sex hormone
mutual suppression
nuclear
hormone receptors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17639/01A
Inventor
Chawnshang Chang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Rochester
Original Assignee
University of Rochester
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Rochester filed Critical University of Rochester
Publication of AU1763901A publication Critical patent/AU1763901A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/10—Screening for compounds of potential therapeutic value involving cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU17639/01A 1999-11-12 2000-11-13 Mutual suppression between sex hormone receptors and other nuclear receptors Abandoned AU1763901A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16530099P 1999-11-12 1999-11-12
US60165300 1999-11-12
PCT/US2000/031189 WO2001035101A2 (en) 1999-11-12 2000-11-13 Mutual suppression between sex hormone and other nuclear receptors

Publications (1)

Publication Number Publication Date
AU1763901A true AU1763901A (en) 2001-06-06

Family

ID=22598340

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17639/01A Abandoned AU1763901A (en) 1999-11-12 2000-11-13 Mutual suppression between sex hormone receptors and other nuclear receptors

Country Status (2)

Country Link
AU (1) AU1763901A (en)
WO (1) WO2001035101A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1386157A4 (en) * 2001-04-06 2005-06-22 Univ Rochester SUPPRESSION OF ANDROGEN RECEPTOR TRANSACTIVATION BY NEW PATHWAYS TO RA AND RA CO-ACTIVATORS AND REPRESSORS
DE10150183A1 (en) * 2001-10-12 2003-04-24 Max Delbrueck Centrum Use of the orphan receptor TR4 and related compounds, for diagnosis and treatment of tumors and blood diseases, especially leukemia, and for drug screening

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7098310B1 (en) * 1991-12-24 2006-08-29 Ligand Pharmaceuticals Heterodimers of retinoid X receptors (RXRS) and other steroid hormone receptors

Also Published As

Publication number Publication date
WO2001035101A3 (en) 2002-01-17
WO2001035101A2 (en) 2001-05-17

Similar Documents

Publication Publication Date Title
EP1100011A3 (en) Scriptor and interpreter
AU3233400A (en) Fire suppression composition and device
AU3956900A (en) Substituted imidazoles, their preparation and use
IL147296A0 (en) Imidazoimidazoles and triazoles as anti-inflammatory agents
AU6074300A (en) Cardiac reinforcement devices and methods
AU3620600A (en) Skin-marking devices and their use
AU3033100A (en) Substituted imidazoles, their preparation and use
AU1926000A (en) Pth1r and pth3r receptors
AU4134101A (en) Hormone receptor functional entities and methods of their use
AU1968400A (en) Human vanilloid receptors and their uses
AU4834900A (en) Antagonists of gonadotropin releasing hormone
HUP0201874A3 (en) Pesticidal indazole and benzotriazole derivatives, preparation and use thereof
AU6232300A (en) Receptors and associated proteins
AU3075200A (en) Telephone and telephone system
AU1221801A (en) Nanosized intermetallic powders
AU6351199A (en) Pectins and the preparation thereof
AU1744700A (en) Human neurotensin subtype 2 receptor
GB9928805D0 (en) Compounds active at the Glucocorticoid and Thyroid Hormone Receptors
EP1242074A4 (en) 5-benzyl-octahydroindole and 6-benzyl-decahydroquinoline nmda/nr2b antagonists
AU1053501A (en) Polyazanaphthalene compound and medicinal use thereof
AU1763901A (en) Mutual suppression between sex hormone receptors and other nuclear receptors
AU2001275362A1 (en) Nuclear hormone receptors
AU7615200A (en) Vasopressin agonist formulation and process
AU7559200A (en) Hypertriglyceridemia remedies and antiobestics
AU5696400A (en) Improved software interface agent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase